0KSX.LSE Quest Diagnostics Inc.

Healthcare Commercial Services & Supplies London Exchange
- USD
Market cap
-
P/E
16.6x
P/B
-
ROE
15.4%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 0KSX.LSE undervalued?

Graham number

The Graham number of Quest Diagnostics Inc. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Quest Diagnostics Inc. fundamental analysis

No fundamental analysis for Quest Diagnostics Inc. yet.

Quest Diagnostics Inc. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Quest Diagnostics Inc.

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides services under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consum…

Full company profile